Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • Sistem İçeriği
  • Analiz
  • Talep/Soru
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Bozkaya, Halil" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Yükleniyor...
    Küçük Resim
    Öğe
    Comparison of outcomes between endovascular treatment and bypass surgery in Takayasu arteritis: comment on the article by Lee et al
    (Informa Healthcare, 2014) Beşir, Fahri Halit; Bozkaya, Halil; Çınar, Celal; Oğuz, Emrah; Parıldar, Mustafa; Posacıoğlu, Hakan
    …
  • Yükleniyor...
    Küçük Resim
    Öğe
    Minimally Invasive Treatment of Giant Haemangiomas of the Liver: Embolisation With Bleomycin
    (Springer, 2014) Bozkaya, Halil; Çınar, Celal; Beşir, Fahri Halit; Parıldar, Mustafa; Oran, İsmail
    The management of patients with giant haemangioma of the liver remains controversial. Although the usual treatment method for symptomatic giant haemangioma is surgery, the classical paradigm of operative resection remains. In this study, we evaluated the symptomatic improvement and size-reduction effect of embolisation with bleomycin mixed with lipiodol for the treatment of symptomatic giant hepatic haemangioma. This study included 26 patients [21 female, five male; age 41-65 years (mean 49.83 +/- A 1.53)] with symptomatic giant haemangioma unfit for surgery and treated with selective embolisation by bleomycin mixed with lipiodol. The patients were followed-up (mean 7.4 +/- A 0.81 months) clinically and using imaging methods. Statistical analysis was performed using SPSS version 16.0, and p < 0.05 was considered to indicate statistical significance. Embolisation of 32 lesions in 26 patients was performed. The mean volume of the haemangiomas was 446.28 +/- A 88 cm(3) (range 3.39-1559 cm(3)) before intervention and 244.43 +/- A 54.38 cm(3) (range 94-967 cm(3)) after intervention. No mortality or morbidity related to the treatment was identified. Symptomatic improvement was observed in all patients, and significant volume reduction was achieved (p = 0.001). The morbidity of surgical treatment in patients with giant liver hemangioma were similar to those obtained in patients followed-up without treatment. Therefore, follow-up without treatment is preferred in most patients. Thus, minimally invasive embolisation is an alternative and effective treatment for giant symptomatic haemangioma of the liver.
  • Yükleniyor...
    Küçük Resim
    Öğe
    Two Different Treatment Options for Intramuscular Plantar Hemangioma: Surgery Versus Percutaneous Sclerotherapy
    (Elsevier Science Inc, 2014) Uslu, Mustafa; Beşir, Halit; Turan, Hakan; Bozkaya, Halil; Erdem, Havva
    Intramuscular hemangiomas are benign neoplasms usually seen in children and adolescents. They tend to occur in the deep fascia and muscle and more often in the lower extremity, although they are rarely encountered in the plantar musculature. Surgical excision, ultrasound- or fluoroscopic-guided percutaneous sclerotherapy, and angiographic embolization are all treatment options. Surgical excision is the most prevalent form of therapy, although this can be difficult in the hands and feet. For this reason, ultrasound- and fluoroscopic-guided percutaneous sclerotherapy is a useful treatment option for pedal intramuscular hemangioma. In the present report, we describe 2 cases of intramuscular hemangioma in children, 1 treated by excision and 1 by percutaneous sclerosis. (C) 2014 by the American College of Foot and Ankle Surgeons. All rights reserved.

| Düzce Üniversitesi | Kütüphane | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Düzce Üniversitesi, Kütüphane ve Dokümantasyon Daire Başkanlığı, Düzce, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2026 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim